Nanoantibiotics: Functions and Properties at the Nanoscale to Combat Antibiotic Resistance

Abstract

One primary mechanism for bacteria developing resistance is frequent exposure to antibiotics. Nanoantibiotics (nAbts) is one of the strategies being explored to counteract the surge of antibiotic resistant bacteria. nAbts are antibiotic molecules encapsulated with engineered nanoparticles (NPs) or artificially synthesized pure antibiotics with a size range of ≤100 nm in at least one dimension. NPs may restore drug efficacy because of their nanoscale functionalities. As carriers and delivery agents, nAbts can reach target sites inside a bacterium by crossing the cell membrane, interfering with cellular components, and damaging metabolic machinery. Nanoscale systems deliver antibiotics at enormous particle number concentrations. The unique size-, shape-, and composition-related properties of nAbts pose multiple simultaneous assaults on bacteria. Resistance of bacteria toward diverse nanoscale conjugates is considerably slower because NPs generate non-biological adverse effects. NPs physically break down bacteria and interfere with critical molecules used in bacterial processes. Genetic mutations from abiotic assault exerted by nAbts are less probable. This paper discusses how to exploit the fundamental physical and chemical properties of NPs to restore the efficacy of conventional antibiotics. We first described the concept of nAbts and explained their importance. We then summarized the critical physicochemical properties of nAbts that can be utilized in manufacturing and designing various nAbts types. nAbts epitomize a potential Trojan horse strategy to circumvent antibiotic resistance mechanisms. The availability of diverse types and multiple targets of nAbts is increasing due to advances in nanotechnology. Studying nanoscale functions and properties may provide an understanding in preventing future outbreaks caused by antibiotic resistance and in developing successful nAbts.

The Emerging Role of Ionic Liquid-Based Approaches for Enhanced Skin Permeation of Bioactive Molecules: A Snapshot of the Past Couple of Years

“…In line with this, multiple benefits of SLNs/NLCs-mediated delivery of natural and synthetic antimicrobials have been advocated in the recent literature [ 81 , 82 , 83 ], including for fighting multidrug-resistant (MDR) infections [ 84 , 85 ]. Thus, a new “nanoantibiotic era” is on the rise [ 86 ] that will likely have great impact on the management of complicated skin and skin structure infections (cSSTI), given the unique ability of lipid-based NCs to overcome the skin barrier [ 87 ]. One illustrative example is “nanoRIF”, a rifampicin-loaded hybrid lipidic/polymeric NC that showed in vivo efficacy against Staphylococcus aureus -associated infection on skin [ 88 ].…”

Nanoantibiotics Based in Mesoporous Silica Nanoparticles: New Formulations for Bacterial Infection Treatment

“…In the last decade, the concept of nanoantibiotic as delivery-carrier is beginning to emerge as a very powerful therapy in the field of bacterial infection [22]. A drug delivered through nanoparticulate forms can release and specifically connect to cellular and intracellular targets, provoking much greater antimicrobial efficiency compared to the antibiotic isolated [75].…”

“…and metal oxide (ZnO, CuO, TiO 2 , etc.) nanoparticles [18][19][20] and nanoparticles acting as nanocarriers of antimicrobial agents, the so-called nanoantibiotics [21,22].…”

State of the Art in the Antibacterial and Antiviral Applications of Carbon-Based Polymeric Nanocomposites

“…Nanomaterials can restore antibiotic efficacy because of their nanoscale functionalities. As carriers and delivery agents, they can reach target sites inside a bacterium by crossing the cell membrane, causing the leakage of the cellular components, and damaging its metabolism [5]. The smaller size of nanomaterials compared to their bulk counterparts modifies their physicochemical properties, leading to enhanced effectivity.…”